Search results
Who Let The Dog Out?
TheStreet.com· 11 hours agoNow that Chewy is off its leash, will it continue to be a good boy?
Solana-Ether Ratio Hits 3-Month Low, Analyst Anticipates Further Losses
CoinDesk via Yahoo Finance· 15 hours agoThe market has since behaved as expected, with the ratio between SOL and ETH's dollar-denominated...
Price analysis 6/19: BTC, ETH, BNB, SOL, XRP, DOGE, TON, ADA, SHIB, AVAX
The Cointelegraph· 1 day agoWill Bitcoin rebound off its strong support, pulling the altcoins higher? Bitcoin reached the bottom of its $64,602 to $72,000 range on June 18. The failure of the bulls to start a strong rebound ...
Lennar Stock Drops After Home Deliveries Forecast Falls Short of Estimates
Investopedia via Yahoo Finance· 3 days agoWatch This Key Price Level Source: TradingView.com Key Takeaways Lennar shares dropped in extended...
World's Biggest S&P 500 ETF Bleeds Outflows: Why Isn't The Market Crashing? - iShares Core S&P 500...
Benzinga· 3 hours agoThe SPY ETF, with $526 billion in AUM, is experiencing large outflows, possibly due to its high...
Boeing Stock on Radar After Reportedly Delaying 737 Output Targets
Investopedia via Yahoo Finance· 4 days agoWatch These Key Chart Levels Source: TradingView.com Key Takeaways Boeing shares remain on the radar...
Is Shiba Inu’s Rally a Dead Cat Bounce, or the Start of a Recovery? By Coin Edition
Investing.com· 1 day agoDespite the recent price uptick, Shiba Inu’s 24-hour trading volume has dropped by 25.61% to...
Monero's XMR Token Reverses February Slide With Golden Cross
CoinDesk via Yahoo Finance· 18 hours agoIt has taken XMR four months to recoup the slide. The cryptocurrency briefly topped $180 last week,...
DeFi Technologies Stock Sell-Off Is 'Attractive Buying Opportunity,' Benchmark Says
CoinDesk via Yahoo Finance· 10 hours agoThe stock lost nearly half of its value earlier this week following the tumble in altcoins and after...
Gilead Stock Surges on Strong Results in HIV Drug Study
Investopedia via Yahoo Finance· 5 hours agoGilead shares surged Thursday after a Phase 3 trial of the company's injectable drug lenacapavir...